Neogen CORP Schedule 13G passive stakes

Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.

NASDAQ
Neuberger Berman Group LLC and its affiliates have reported beneficial ownership of 7.6% of Neogen Corp's common stock as of June 30, 2026.
NASDAQ
Clarkston Capital Partners, LLC, along with affiliated entities and individuals, has filed an amended Schedule 13G detailing their beneficial ownership of Neogen Corporation's common stock.
NASDAQ
Vanguard Capital Management has reported beneficial ownership of 11,164,628 shares, representing 5.13% of Neogen Corp's common stock, as of March 31, 2026.
NASDAQ
Vanguard Portfolio Management has reported beneficial ownership of 5.93% of Neogen Corp's common stock as of March 31, 2026.
NASDAQ
The Vanguard Group, Inc. has reported a 0% beneficial ownership in Neogen Corp common stock following an internal realignment effective January 12, 2026.
NASDAQ
ING Groep N.V. and its subsidiary, ING Capital Markets LLC, have filed an amended Schedule 13G disclosing a beneficial ownership of 3.99% in NEOGEN CORP common stock.
NASDAQ
A group of entities and individuals led by Clarkston Capital Partners has reported a 5.38% beneficial ownership stake in Neogen Corp, totaling 11,693,250 common shares.
NASDAQ
ING Groep N.V. and its subsidiary, ING Capital Markets LLC, have jointly reported a beneficial ownership of 6.47% in NEOGEN Corp's common stock.
NASDAQ
Gates Capital Management and its affiliates have disclosed a passive 5.9% beneficial ownership stake in Neogen Corporation's common stock.
NASDAQ
A group of entities and individuals led by Clarkston Capital Partners, LLC has disclosed a beneficial ownership of 6.44% in Neogen Corporation's common stock.
NASDAQ
William Blair Investment Management, LLC has filed an amended Schedule 13G, disclosing a 4.3% beneficial ownership stake in Neogen Corp's common stock.
NASDAQ
Norges Bank, acting on behalf of the Government of Norway, has reported a 4.2% beneficial ownership stake in Neogen Corp's common stock as of June 30, 2025.
NASDAQ
BlackRock, Inc. has filed an Amendment No. 17 to its Schedule 13G, reporting a 14.3% beneficial ownership stake in NEOGEN CORP as of March 31, 2025.
NASDAQ
Norges Bank, the central bank of Norway, has filed an amended Schedule 13G disclosing a beneficial ownership of 6.8% in Neogen Corp's common stock as of March 31, 2025.
NASDAQ
The Vanguard Group has filed an amended Schedule 13G, reporting a beneficial ownership of 10.85% in Neogen Corp's common stock as of March 31, 2025.
NASDAQ
Select Equity Group, L.P. and George S. Loening have filed an amended Schedule 13G, disclosing a passive beneficial ownership of 4.3% in Neogen Corp's common stock as of December 31, 2024.
NASDAQ
Investment manager Baillie Gifford & Co. has filed an amended Schedule 13G, disclosing a reduction in its beneficial ownership of NEOGEN CORP common stock to 4.5% as of December 31, 2024.